(Q35554703)

English

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

scientific article published on November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

26

object named as

Rainer Storb

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Brenda M Sandmaier

2

object named as

Brenda M Sandmaier

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

3

object named as

Barry E Storer

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Thomas R Chauncey

6

object named as

Thomas R Chauncey

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Marco Mielcarek

21

object named as

Marco Mielcarek

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

David G. Maloney

25

object named as

David G Maloney

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Dietger Niederwieser

23

object named as

Dietger Niederwieser

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Mohamed L Sorror

1

object named as

Mohamed L Sorror

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Benedetto Bruno

14

object named as

Benedetto Bruno

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Michael A Pulsipher

11

object named as

Michael A Pulsipher

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Richard Maziarz

8

object named as

Richard T Maziarz

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

7

object named as

Edward Agura

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Parameswaran Hari

10

object named as

Parameswaran Hari

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Amelia A Langston

9

object named as

Amelia Langston

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Firoozeh Sahebi

13

object named as

Firoozeh Sahebi

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

24

object named as

Karl G Blume

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Finn Peter Petersen

17

object named as

Finn Bo Petersen

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

5

object named as

Ginna G Laport

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

18

object named as

Lars Vindeløv

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

20

object named as

Kai Hübel

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

George E Georges

22

object named as

George E Georges

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Georg-Nikolaus Franke

4

object named as

Georg N Franke

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

author name string

Wolfgang Bethge

12

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Michael B Maris

15

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Andrew Yeager

16

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Peter A McSweeney

19

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

The Journal of the American Medical Association

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

306

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1874-1883

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Reduced mortality after allogeneic hematopoietic-cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Future of cancer incidence in the United States: burdens upon an aging, changing nation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Age and acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Efficacy of lenalidomide in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Association of comorbidity with disability in older women: the Women's Health and Aging Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Modelling prevalence of a condition: chronic graft-versus-host disease after bone marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

12 July 2018

Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

26 September 2018

Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

26 September 2018

Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

26 September 2018

Duration of immunosuppressive treatment for chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

26 September 2018

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

26 September 2018

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

26 September 2018

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

26 September 2018

The aging of the immune system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217787

15 November 2018

Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22045765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient

1 reference

https://pubmed.ncbi.nlm.nih.gov/22045765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22045765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22045765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22045765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of allogeneic-cell transplantation in leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22045765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/JAMA.2011.1558

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

release_so2ueet55vhbdhw2rmjznyd6vm

1 reference

https://api.fatcat.wiki/v0/release/so2ueet55vhbdhw2rmjznyd6vm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35554703&oldid=1840191300"